These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 754435)

  • 21. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
    Susskind BM; Chandrasekaran J
    J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of soluble cell product released by live thymocytes on lymphocyte movements in vivo.
    Davies MD; Curtis AS
    Thymus; 1981 Jun; 3(1):35-42. PubMed ID: 6973842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of human recombinant interleukin 2 on in vitro tumor cytotoxicity in dogs.
    Raskin RE; Holcomb CS; Maxwell AK
    Am J Vet Res; 1991 Dec; 52(12):2029-32. PubMed ID: 1789517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of inhibition of human natural killer activity by ultraviolet radiation.
    Weitzen ML; Bonavida B
    J Immunol; 1984 Dec; 133(6):3128-32. PubMed ID: 6491282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctes.
    Jeffes EW; Granger GA
    J Immunol; 1975 Jan; 114(1 Pt 1):64-9. PubMed ID: 1078679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.
    Sayers TJ; Ransom JH; Denn AC; Herberman RB; Ortaldo JR
    J Immunol; 1986 Jul; 137(1):385-90. PubMed ID: 2423611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
    Peter HH; Eife RF; Kalden JR
    J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro.
    Gao X; Kuo J; Jiang H; Deeb D; Liu Y; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
    Biochem Pharmacol; 2004 Jul; 68(1):51-61. PubMed ID: 15183117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel lymphokine derived from human IgG Fc receptor-bearing B cells: its suppressive effect on activated T and B lymphocytes including tumour cells in vitro.
    Suzuki T; Park YH; Miyama-Inaba M; Masuda T; Saji H; Nagata I; Uchino H
    Immunology; 1985 Jul; 55(3):427-36. PubMed ID: 3160654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activation of mouse macrophages by rat lymphocyte mediators.
    Fidler IJ; Darnell JH; Budmen MB
    J Immunol; 1976 Aug; 117(2):666-73. PubMed ID: 950467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes.
    Chuang LT; Lotzová E; Cook KR; Cristoforoni P; Morris M; Wharton JT
    Gynecol Oncol; 1993 Jun; 49(3):291-8. PubMed ID: 8100207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of stimulator-induced cytotoxicity of human mononuclear cells in short-term culture].
    von Baehr R; Timm M; Fröbe I
    Allerg Immunol (Leipz); 1983; 29(2):87-92. PubMed ID: 6224413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of interferon in human lymphocytes stimulated "in vitro" by antilymphocytic serum.
    Falcoff E; Falcoff R; Catinot L; de Vomecourt A; Sanceau J
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):20-6. PubMed ID: 5041346
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphokines and thrombosis. Effect of lymphokines on fibrinolysis. Release of fibrinolytic activity by human leucocytes stimulated with lymphokines.
    Coeugniet E
    Thromb Haemost; 1979 Dec; 42(4):1240-7. PubMed ID: 542931
    [No Abstract]   [Full Text] [Related]  

  • 39. A lymphokine-like factor isolated by deoxycholate from the membrane of human lymphocytes.
    Hrabák A; Antoni F; Szabó MT
    Biochim Biophys Acta; 1980 Oct; 602(1):87-96. PubMed ID: 7417452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukoregulin inhibits the growth of human glioblastoma in vitro.
    Merchant RE; Ransom JH; Young HF
    J Neuroimmunol; 1986 Nov; 13(1):31-45. PubMed ID: 3760159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.